Our Clinical Research
The following research studies have been presented at international conferences and published in conference proceedings
Conference: ASM Microbe 2022 – Washington, DC, USA, June 09-13, 2022
Monitoring Resistance Profiles of Oral Agents Used in the Treatment of Urinary Tract Infections, as Determined by the Novel Weighted-Incidence Syndromic Combination Antibiogram (WISCA) Resistance (WISCA-R) Profiling Method: A Four-Year Study
Virtual Conference: World Microbe Forum 2021 (ASM Microbe-FEMS 2021), June 20-24, 2021
Resistance Profiles of Oral Agents Used in the Treatment of Urinary Tract Infections as Determined by the Novel Weighted-Incidence Syndromic Combination Antibiogram (WISCA) Resistance (WISCA-R) Profiling Method, and Comparison to Previous WISCA-R Findings
Virtual Conference: ASM Microbe 2020 (ASMGM-ICAAC 2020), July 24-28, 2020
Novel Weighted-Incidence Syndromic Combination Antibiogram (WISCA) Resistance (WISCA-R) Profiling of Oral Agents Commonly Used in the Treatment of Community Urinary Tract Infections, and Comparison to Previous WISCA-R Findings
Conference: ASM Microbe 2019 (ASMGM-ICAAC 2019), San Francisco, CA, USA, June 20-24, 2019
Construction of Weighted Incidence Syndromic Combination Antibiogram (WISCA) Resistance Profiles of Oral Agents Tested against Community Urinary Isolates, and Comparison to Physician Empiric Choice
Conference: ASM Microbe 2018 (ASM-ICAAC 2018), Atlanta, GA, USA June 07-11, 2018
Determination of Oral Antimicrobial Agents with the Lowest Resistance Rates among Community Urinary Isolates
Conference: ASM Microbe (ASM-ICAAC), New Orleans, LA, USA, June 01-05, 2017
Antimicrobial Resistance of Urinary Isolates from Non-Hospitalized Pregnant Women
Conference: ASM Microbe (ASM-ICAAC), Boston, MA, USA June 16-20, 2016
Fosfomycin Has the Lowest Resistance Rate among Oral Antimicrobial Agents Tested against Community Uropathogens
Conference: American Society for Microbiology General Meeting, Boston, MA, USA, May 2014
Antimicrobial Resistance of Urinary Gram-Negative Bacilli Recovered from Pregnant Patients
Conference: American Society for Microbiology General Meeting, Denver, CO, USA, May 2013
Tracking Methicillin-Resistant Staphylococcus aureus among Community Clinical Isolates: A Five-Year Study
Conference: American Society for Microbiology General Meeting, San Francisco, CA (USA), June 2012
Increasing Rates of Extended-Spectrum Beta-Lactamase (ESBL) Producing Strains among Community Urinary Isolates and Impact of Patient Age on ESBL Prevalence and Resistance Rates: A Five-Year Study
Conference: American Society for Microbiology General Meeting, New Orleans, LA (USA), May 2011
Prevalence of Multidrug-Resistant Gram-Negative Bacilli (MDR-GNBs) among Community Urinary Isolates and Impact of Patient Age on MDR-GNB Prevalence and Resistance Rates
Conference: American Society for Microbiology General Meeting, San Diego, CA (USA), May 2010
Prevalence of Antimicrobial Resistance of Community Urinary Isolates against First-line Antimicrobial Agents Commonly Used in the Treatment of Uncomplicated Urinary Tract Infections, and Impact of Age on Resistance Rates
Conference: American Society for Microbiology General Meeting, Philadelphia, PA (USA), May 2009
Enhanced Recovery of Low-Inoculum Methicillin-Resistant Staphylococcus aureus (MRSA) by the Novel Flocked ESwab Compared to a Conventional Swab, the M40 Transystem